Log in/ Sign up

About LSC

Last Survivor is a metaverse project based on Binance Smart Chain. It makes the most of the MOBA and Battle Royale in the Fighters' survival battle in the futuristic fantasy world. Your goal is to be the last on the battlefield to win the game. Last Survivor is the newest free-to-earn battle royale game, fast and easy to play.Last Survivor Highlights:The best Battle Royale Metaverse on blockchain Free to earn with two-token system, free and NFT fighters Diverse and thrilling game modes: PVE, Arena, Solo/Duo/Squad battle, Custom battle Character NFT, Item NFT drop events Land NFT: buy/sell land NFT, biding on providing new custom maps and get profit from it Chat, talk, role play, team-up with other players to fight against boss events or tournaments Community driven game play governed by DAO Gamer-focused game systems: ranking, leaderboard, guild and battle pass

Last Survivor (LSC) is a cryptocurrency launched in 2021. LSC has a current supply of 1.20Bn with 0 in circulation. The last known price of LSC is 0.000002843665 USD and is 0.000000093213 over the last 24 hours. It is currently trading on active market(s) with $0 traded over the last 24 hours. More information can be found at https://lastsurvivor.io.

Official Website

Social Media

LSC Price Statistics
LSC’s Price Today
24h Price Change
+$0.0000000932133.39%
24h Volume
$00.00%
24h Low / 24h High
$0 / $0
Volume / Market Cap
--
Market Dominance
0.00%
Market Rank
#15418
LSC Market Cap
Market Cap
$0
Fully Diluted Market Cap
$3,412.40
LSC Price History
7d Low / 7d High
$0 / $0
All-Time High
$0
All-Time Low
$0
LSC Supply
Circulating Supply
0
Total Supply
1.20Bn
Max Supply
1.20Bn
Updated Sep 19, 2026 2:59 am
image
LSC
Last Survivor
$0.000002843665
$0.000000093213(+3.39%)
Mkt Cap $0
There's nothing here for now
Planet Morning News
Planet Morning News
Sep 19, 2026 9:30 am
SEC Receives Amended S-1/A for 21Shares Injective ETF as Altcoin ETF Race Heats Up
SEC Receives Amended S-1/A for 21Shares Injective ETF as Altcoin ETF Race Heats Up
The SEC has received an amended registration statement for the 21Shares Injective ETF, moving the proposed fund a step closer to becoming a publicly traded product, according to Crypto Briefing. The amended S-1/A updates the original October 2025 filing and would give traditional investors regulated access to INJ, the native token of the Injective Network. If approved, the ETF would list on Nasdaq under the ticker TINJ, passively tracking INJ via the FTSE Injective Index, with a twist: discretionary staking of a portion of holdings to boost returns. Structured as a Delaware statutory trust and sponsored by 21Shares US LLC, the fund's original S-1 landed on October 20, 2025, and the latest amendment keeps the registration active as the review continues. The preliminary prospectus notes shares have not traded publicly and no financial statements are included yet. INJ staking rewards ranged from 9.3% to 13.62% annually in 2025, giving the ETF a yield dimension most equity-focused products cannot match. As of September 1, 2026, INJ's circulating supply stood at about 92.8 million tokens, with a market capitalization near $488 million. 21Shares is no stranger to wrapping digital assets in traditional packaging, already offering a 21Shares Injective Staking ETP to European investors and having been among the first issuers of spot Bitcoin and Ethereum ETFs via its ARK 21Shares Bitcoin ETF partnership. Since spot Bitcoin ETFs launched in January 2024 and Ethereum products followed later that year, asset managers have raced to file for funds covering Solana, XRP, Litecoin, Cardano and a growing list of layer-1 and DeFi tokens. Injective is a layer-1 blockchain built on the Cosmos SDK for decentralized finance, focused on decentralized exchanges, derivatives and cross-chain trading. Its low-double-digit staking yield offers a tailwind pure price-tracking products can't replicate. The $488 million market cap is notable: for comparison, Bitcoin's is in the trillions and Ethereum's typically above $200 billion, so an INJ ETF drawing even tens of millions could represent a meaningful share of the token's float. The choice of the FTSE Injective Index — from London Stock Exchange Group's FTSE Russell — is also notable as the firm expands its digital-asset indexes, while custody arrangements remain unfinalized, a detail the SEC will likely want settled before any approval.
Sep 19, 2026 9:16 am

Frequently Asked Questions

  • What is the all-time high price of Last Survivor (LSC)?

    The all-time high of LSC was 0 USD on 1970-01-01, from which the coin is now down 0%. The all-time high price of Last Survivor (LSC) is 0. The current price of LSC is down 0% from its all-time high.

    Read More
  • How much Last Survivor (LSC) is there in circulation?

    As of , there is currently 0 LSC in circulation. LSC has a maximum supply of 1.20Bn.

    Read More
  • What is the market cap of Last Survivor (LSC)?

    The current market cap of LSC is 0. It is calculated by multiplying the current supply of LSC by its real-time market price of 0.000002843665.

    Read More
  • What is the all-time low price of Last Survivor (LSC)?

    The all-time low of LSC was 0 , from which the coin is now up 0%. The all-time low price of Last Survivor (LSC) is 0. The current price of LSC is up 0% from its all-time low.

    Read More
  • Is Last Survivor (LSC) a good investment?

    Last Survivor (LSC) has a market capitalization of $0 and is ranked #15418 on CoinMarketCap. The cryptocurrency market can be highly volatile, so be sure to do your own research (DYOR) and assess your risk tolerance. Additionally, analyze Last Survivor (LSC) price trends and patterns to find the best time to purchase LSC.

    Read More